• Follow us on Twitter

Follow us on Twitter:

The RTCure project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement no 777357. This joint undertaking receives support from the European Union's Horizon 2020 Research and Innovation Programme and EFPIA.

The communication reflects the author's view; neither IMI nor the European Union or EFPIA  are responsible for any use that may be made of the information contained herein.

General project information

WP1 

Management, coordination, dissemination and sustainability

WP2 

Cohorts

WP3

Mechanisms of Immune Tolerance

WP4

Technologies for monitoring the RA-associated immune state

WP6

Clinical studies

WP7

Ethics requirements

WP5 

Bioinformatics and data